![](/img/cover-not-exists.png)
Regorafenib (BAY 73-4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
Scott M. Wilhelm, Jacques Dumas, Lila Adnane, Mark Lynch, Christopher A. Carter, Gunnar Schütz, Karl-Heinz Thierauch, Dieter ZopfVolume:
129
Year:
2011
Language:
english
Pages:
11
DOI:
10.1002/ijc.25864
File:
PDF, 1.30 MB
english, 2011